Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-09

Clinical Trial Update: Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compared patient-adjusted versus physician-adjusted titration of BIAsp 30 combined with metformin in adults with Type 2 diabetes; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIAsp-30 (biphasic insulin aspart protamine 30% / insulin aspart 70%)
  • metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2016-08-09